Search Results

Single-Inhaler Combination Therapy for Maintenance and Relief of Asthma: A New Strategy in Disease Management

Author: Peters, Matthew

Source: Drugs, Volume 69, Number 2, 2009 , pp. 137-150(14)

Publisher: Adis International

Molecule of the Month

Authors: Bolinger, Julie D.; Lindsley, Craig W.

Source: Current Topics in Medicinal Chemistry, Volume 7, Number 16, August 2007 , pp. 1643-1643(1)

Publisher: Bentham Science Publishers

Salmeterol/Fluticasone Propionate: A Review of its Use in the Treatment of Chronic Obstructive Pulmonary Disease

Authors: Keating, Gillian M.; McCormack, Paul L.

Source: Drugs, Volume 67, Number 16, 2007 , pp. 2383-2405(23)

Publisher: Adis International

Building strong condition brands

Authors: Angelmar, Reinhard; Angelmar, Sarah; Kane, Liz

Source: Journal of Medical Marketing, Volume 7, Number 4, September 2007 , pp. 341-351(11)

Publisher: Palgrave Macmillan

Inhaled Glucocorticosteroid and Long-Acting β2-Adrenoceptor Agonist Single-Inhaler Combination for Both Maintenance and Rescue Therapy: A Paradigm Shift in Asthma Management

Author: D'Urzo, Anthony D.

Source: Treatments in Respiratory Medicine, Volume 5, Number 6, 2006 , pp. 385-391(7)

Publisher: Adis International

GlaxoSmithKline has launched its salmeterol/fluticasone propionate metered-dose inhaler [Advair HFA Inhalation Aerosol] in the US.

Source: Inpharma, Volume 1, Number 1562, 2006-11-04 , pp. 22-22(1)

Publisher: Adis International

Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: performance and patient satisfaction

Authors: SHETH, K.; WASSERMAN, R. L.; LINCOURT, W. R.; LOCANTORE, N. W.; CARRANZA-ROSENZWEIG, J.; CRIM, C.

Source: International Journal of Clinical Practice, Volume 60, Number 10, October 2006 , pp. 1218-1224(7)

Publisher: Blackwell Publishing

Symptom Perception and Adherence to Asthma Controller Medications

Authors: Ohm, Ruth; Aaronson, Lauren S.

Source: Journal of Nursing Scholarship, Volume 38, Number 3, September 2006 , pp. 292-297(6)

Publisher: Blackwell Publishing

GSK agrees with FDA: new US labelling for Advair and Serevent

Source: Inpharma, Volume 1, Number 1529, 2006-03-18 , pp. 17-17(1)

Publisher: Adis International

GSK agrees with FDA: new US labelling for Advair and Serevent

Source: Reactions, Volume 1, Number 1093, 2006-03-18 , pp. 2-2(1)

Publisher: Adis International

GlaxoSmithKline (GSK) disagrees with the US FDA's proposed labelling changes for Advair [salmeterol/fluticasone propionate] and Serevent

Source: Reactions, Volume 1, Number 1079, 2005-11-26 , pp. 2-2(1)

Publisher: Adis International

GlaxoSmithKline (GSK) disagrees with the US FDA's proposed labelling changes for Advair [salmeterol/fluticasone propionate] and Serevent

Source: Inpharma, Volume 1, Number 1515, 2005-11-26 , pp. 17-17(1)

Publisher: Adis International

Combination Inhalers Containing Inhaled Corticosteroids and Long-Acting β 2 -Agonists: Improved Clinical Efficacy and Dosing Options in Patients with Asthma

Author: Ankerst, Jaro

Source: Journal of Asthma, Volume 42, Number 9, 2005 , pp. 715-724(10)

Publisher: Informa Healthcare

The Prevalence of Reversible Airflow Obstruction and/or Methacholine Hyperreactivity in Random Adult Asthma Patients Identified by Administrative Data

Authors: Macy, Eric; Schatz, Michael; Gibbons, Carlene; Zeiger, Robert

Source: Journal of Asthma, Volume 42, Number 3, April 2005 , pp. 213-220(8)

Publisher: Informa Healthcare

Inhaled Salmeterol/Fluticasone Propionate: A Review of its Use in Asthma

Authors: Reynolds, Neil A.; Lyseng-Williamson, Katherine A.; Wiseman, Lynda R.

Source: Drugs, Volume 65, Number 12, 2005 , pp. 1715-1734(20)

Publisher: Adis International

Maintenance Asthma Treatment with Fluticasone/Salmeterol Combination via Diskus: Effect on Outcomes in Inner-City Children Enrolled in TennCare

Authors: Nguyen, William T.; Stewart, Charles; Fisher, Kimberley; Tolley, Elizabeth; Betty Lew, Dukhee; Self, Timothy H.

Source: Allergy and Asthma Proceedings, Volume 26, Number 2, March-April 2005 , pp. 129-134(6)

Publisher: OceanSide Publications, Inc

Short-Term Safety and Tolerability of Double-Dose Salmeterol/Fluticasone Propionate in Adult Asthmatic Patients

Authors: Adolfsson, Lars-Erik; Lundgren, Michael; Tilling, Bjorn; Jern, Sverker; Tyren, Christina; Godwood, Alex; Gor, Dee

Source: Clinical Drug Investigation, Volume 25, Number 4, 2005 , pp. 231-241(11)

Publisher: Adis International

Inhaled Salmeterol/Fluticasone Propionate: A Review of its Use in Chronic Obstructive Pulmonary Disease

Authors: Fenton, Caroline; Keating, Gillian M.

Source: Drugs, Volume 64, Number 17, 2004 , pp. 1975-1996(22)

Publisher: Adis International

Fluticasone propionate/salmeterol for the treatment of chronic-obstructive pulmonary disease

Authors: Mark T Dransfield; William C Bailey

Source: Expert Opinion on Pharmacotherapy, Volume 5, Number 8, 1 August 2004 , pp. 1815-1826(12)

Publisher: Informa Healthcare

The average wholesale price (AWP) at which Pfizer and Boehringer Ingelheim are launching tiotropium bromide [Spiriva] is 30% less than the AWP of GlaxoSmithKline's salmeterol/fluticasone propionate [Advair]

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 454, 2004-06-05 , pp. 11-11(1)

Publisher: Adis International